{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T06:56:59Z","timestamp":1794553019378,"version":"4.9.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-66061-8","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T10:59:14Z","timestamp":1765450754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Transcytotic transportation of size-controlled nanocarriers into dystrophic skeletal muscle leads to therapeutic outcome in mice"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5719-2838","authenticated-orcid":false,"given":"Xiangsheng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8626-0927","authenticated-orcid":false,"given":"Michael R.","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9793-3661","authenticated-orcid":false,"given":"Zhenhan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney S.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kholoud","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4989-6402","authenticated-orcid":false,"given":"Michael R.","family":"Emami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiulong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yile","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7104-544X","authenticated-orcid":false,"given":"Melissa J.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6122-1649","authenticated-orcid":false,"given":"April D.","family":"Pyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8844-3938","authenticated-orcid":false,"given":"Huan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"66061_CR1","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41578-021-00315-x","volume":"6","author":"J Wang","year":"2021","unstructured":"Wang, J., Li, Y. & Nie, G. Multifunctional biomolecule nanostructures for cancer therapy. Nat. Rev. Mater. 6, 766\u2013783 (2021).","journal-title":"Nat. Rev. Mater."},{"key":"66061_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2020.101008","volume":"35","author":"C Zhang","year":"2020","unstructured":"Zhang, C. et al. Progress, challenges, and future of nanomedicine. Nano Today 35, 101008 (2020).","journal-title":"Nano Today"},{"key":"66061_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1472","volume":"10","author":"ME Nance","year":"2018","unstructured":"Nance, M. E., Hakim, C. H., Yang, N. N. & Duan, D. Nanotherapy for Duchenne muscular dystrophy. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 10, e1472 (2018).","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"66061_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2022.101544","volume":"46","author":"X Xie","year":"2022","unstructured":"Xie, X. et al. Interleukin\u221210 plasmid delivery by polymeric nanocarrier shows efficient and safe tissue repair in acute muscle damage models in mice. Nano Today 46, 101544 (2022).","journal-title":"Nano Today"},{"key":"66061_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2022.101482","volume":"44","author":"P Yang","year":"2022","unstructured":"Yang, P. et al. Nano-vectors for CRISPR\/Cas9-mediated genome editing. Nano Today 44, 101482 (2022).","journal-title":"Nano Today"},{"key":"66061_CR6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41582-019-0203-3","volume":"15","author":"IE Verhaart","year":"2019","unstructured":"Verhaart, I. E. & Aartsma-Rus, A. Therapeutic developments for Duchenne muscular dystrophy. Nat. Rev. Neurol. 15, 373\u2013386 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"66061_CR7","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/s41587-023-01886-6","volume":"41","author":"J Hodgson","year":"2023","unstructured":"Hodgson, J. Drug pipeline 2Q23 - controversy and complexity. Nat. Biotechnol. 41, 1041\u20131043 (2023).","journal-title":"Nat. Biotechnol."},{"key":"66061_CR8","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1080\/14712598.2022.2060737","volume":"22","author":"TK Kishimoto","year":"2022","unstructured":"Kishimoto, T. K. & Samulski, R. J. Addressing high dose AAV toxicity\u2014\u2018one and done\u2019 or \u2018slower and lower\u2019? Expert Opin. Biol. Ther. 22, 1067\u20131071 (2022).","journal-title":"Expert Opin. Biol. Ther."},{"key":"66061_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1089\/nat.2013.0450","volume":"24","author":"MS Falzarano","year":"2014","unstructured":"Falzarano, M. S., Passarelli, C. & Ferlini, A. Nanoparticle delivery of antisense oligonucleotides and their application in the exon skipping strategy for Duchenne muscular dystrophy. Nucleic Acid Ther. 24, 87\u2013100 (2014).","journal-title":"Nucleic Acid Ther."},{"key":"66061_CR10","doi-asserted-by":"publisher","first-page":"1900061","DOI":"10.1002\/adtp.201900061","volume":"2","author":"MR Emami","year":"2019","unstructured":"Emami, M. R. et al. Polyrotaxane nanocarriers can deliver CRISPR\/Cas9 plasmid to dystrophic muscle cells to successfully edit the DMD gene. Adv. Ther. 2, 1900061 (2019).","journal-title":"Adv. Ther."},{"key":"66061_CR11","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/s41551-017-0137-2","volume":"1","author":"K Lee","year":"2017","unstructured":"Lee, K. et al. Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair. Nat. Biomed. Eng. 1, 889\u2013901 (2017).","journal-title":"Nat. Biomed. Eng."},{"key":"66061_CR12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3389\/fnagi.2015.00190","volume":"7","author":"ME Randolph","year":"2015","unstructured":"Randolph, M. E. & Pavlath, G. K. A muscle stem cell for every muscle: variability of satellite cell biology among different muscle groups. Front. Aging Neurosci. 7, 190 (2015).","journal-title":"Front. Aging Neurosci."},{"key":"66061_CR13","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1039\/C0CS00018C","volume":"40","author":"N Khlebtsov","year":"2011","unstructured":"Khlebtsov, N. & Dykman, L. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem. Soc. Rev. 40, 1647\u20131671 (2011).","journal-title":"Chem. Soc. Rev."},{"key":"66061_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201704307","volume":"30","author":"J Bourquin","year":"2018","unstructured":"Bourquin, J. et al. Biodistribution, clearance, and long-term fate of clinically relevant nanomaterials. Adv. Mater. 30, e1704307 (2018).","journal-title":"Adv. Mater."},{"key":"66061_CR15","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1172\/JCI92284","volume":"127","author":"X Liu","year":"2017","unstructured":"Liu, X. et al. Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer. J. Clin. Investig. 127, 2007\u20132018 (2017).","journal-title":"J. Clin. Investig."},{"key":"66061_CR16","doi-asserted-by":"publisher","first-page":"8018","DOI":"10.7150\/thno.38587","volume":"9","author":"X Liu","year":"2019","unstructured":"Liu, X., Jiang, J. & Meng, H. Transcytosis\u2014an effective targeting strategy that is complementary to \u201cEPR effect\u201d for pancreatic cancer nano drug delivery. Theranostics 9, 8018\u20138025 (2019).","journal-title":"Theranostics"},{"key":"66061_CR17","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41565-019-0485-z","volume":"14","author":"Q Zhou","year":"2019","unstructured":"Zhou, Q. et al. Enzyme-activatable polymer-drug conjugate augments tumour penetration and treatment efficacy. Nat. Nanotechnol. 14, 799\u2013809 (2019).","journal-title":"Nat. Nanotechnol."},{"key":"66061_CR18","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","volume":"19","author":"S Sindhwani","year":"2020","unstructured":"Sindhwani, S. et al. The entry of nanoparticles into solid tumours. Nat. Mater. 19, 566\u2013575 (2020).","journal-title":"Nat. Mater."},{"key":"66061_CR19","doi-asserted-by":"publisher","first-page":"14080","DOI":"10.1021\/acsnano.1c04510","volume":"15","author":"BR Kingston","year":"2021","unstructured":"Kingston, B. R. et al. Specific endothelial cells govern nanoparticle entry into solid tumors. ACS Nano 15, 14080\u201314094 (2021).","journal-title":"ACS Nano"},{"key":"66061_CR20","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1172\/JCI93955","volume":"127","author":"E Ruoslahti","year":"2017","unstructured":"Ruoslahti, E. Access granted: iRGD helps silicasome-encased drugs breach the tumor barrier. J. Clin. Investig. 127, 1622\u20131624 (2017).","journal-title":"J. Clin. Investig."},{"key":"66061_CR21","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41563-020-0669-9","volume":"19","author":"I de Lazaro","year":"2020","unstructured":"de Lazaro, I. & Mooney, D. J. A nanoparticle\u2019s pathway into tumours. Nat. Mater. 19, 486\u2013487 (2020).","journal-title":"Nat. Mater."},{"key":"66061_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s44222-024-00154-9","volume":"2","author":"LN Nguyen","year":"2024","unstructured":"Nguyen, L. N. et al. The mechanisms of nanoparticle delivery to solid tumours. Nat. Rev. Bioeng. 2, 201\u2013213 (2024).","journal-title":"Nat. Rev. Bioeng."},{"key":"66061_CR23","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41565-025-01877-5","volume":"20","author":"JL Wu","year":"2025","unstructured":"Wu, J. L. et al. The pathways for nanoparticle transport across tumour endothelium. Nat. Nanotechnol. 20, 672\u2013682 (2025).","journal-title":"Nat. Nanotechnol."},{"key":"66061_CR24","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/NEN.0b013e3181e9a34b","volume":"69","author":"L Zhou","year":"2010","unstructured":"Zhou, L. & Lu, H. Targeting fibrosis in Duchenne muscular dystrophy. J. Neuropathol. Exp. Neurol. 69, 771\u2013776 (2010).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"66061_CR25","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.nmd.2004.06.008","volume":"14","author":"A Briguet","year":"2004","unstructured":"Briguet, A. et al. Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse. Neuromuscul. Disord. 14, 675\u2013682 (2004).","journal-title":"Neuromuscul. Disord."},{"key":"66061_CR26","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1158\/1078-0432.CCR-11-3114","volume":"18","author":"C Feig","year":"2012","unstructured":"Feig, C. et al. The pancreas cancer microenvironment. Clin. Cancer Res. 18, 4266\u20134276 (2012).","journal-title":"Clin. Cancer Res."},{"key":"66061_CR27","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ajpath.2012.10.018","volume":"182","author":"OM Dorchies","year":"2013","unstructured":"Dorchies, O. M. et al. The anticancer drug tamoxifen counteracts the pathology in a mouse model of Duchenne muscular dystrophy. Am. J. Pathol. 182, 485\u2013504 (2013).","journal-title":"Am. J. Pathol."},{"key":"66061_CR28","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2533\/chimia.2018.238","volume":"72","author":"E Gayi","year":"2018","unstructured":"Gayi, E. et al. Repurposing the selective oestrogen receptor modulator tamoxifen for the treatment of Duchenne muscular dystrophy. Chimia 72, 238\u2013240 (2018).","journal-title":"Chimia"},{"key":"66061_CR29","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/S1474-4422(22)00125-9","volume":"21","author":"T Markati","year":"2022","unstructured":"Markati, T. et al. Emerging therapies for Duchenne muscular dystrophy. Lancet Neurol. 21, 814\u2013829 (2022).","journal-title":"Lancet Neurol."},{"key":"66061_CR30","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1021\/acsnano.5b00510","volume":"9","author":"H Meng","year":"2015","unstructured":"Meng, H. et al. Use of a Lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice. ACS Nano 9, 3540\u20133557 (2015).","journal-title":"ACS Nano"},{"key":"66061_CR31","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1021\/acsnano.5b07781","volume":"10","author":"X Liu","year":"2016","unstructured":"Liu, X. et al. Irinotecan delivery by lipid-coated mesoporous silica nanoparticles shows improved efficacy and safety over liposomes for pancreatic cancer. ACS Nano 10, 2702\u20132715 (2016).","journal-title":"ACS Nano"},{"key":"66061_CR32","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1021\/acsnano.8b06164","volume":"13","author":"X Liu","year":"2019","unstructured":"Liu, X. et al. Improved efficacy and reduced toxicity using a custom-designed irinotecan-delivering silicasome for orthotopic colon cancer. ACS Nano 13, 38\u201353 (2019).","journal-title":"ACS Nano"},{"key":"66061_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17996-7","volume":"11","author":"Y Ji","year":"2020","unstructured":"Ji, Y. et al. Use of ratiometrically designed nanocarrier targeting CDK4\/6 and autophagy pathways for effective pancreatic cancer treatment. Nat. Commun. 11, 4249 (2020).","journal-title":"Nat. Commun."},{"key":"66061_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202002147","volume":"8","author":"X Liu","year":"2021","unstructured":"Liu, X. et al. Combination chemo-immunotherapy for pancreatic cancer using the immunogenic effects of an irinotecan silicasome nanocarrier plus Anti-PD-1. Adv. Sci. 8, 2002147 (2021).","journal-title":"Adv. Sci."},{"key":"66061_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202005993","volume":"17","author":"X Liu","year":"2021","unstructured":"Liu, X. et al. Development of facile and versatile platinum drug delivering silicasome nanocarriers for efficient pancreatic cancer chemo-immunotherapy. Small 17, e2005993 (2021).","journal-title":"Small"},{"key":"66061_CR36","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nmat2992","volume":"10","author":"CE Ashley","year":"2011","unstructured":"Ashley, C. E. et al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat. Mater. 10, 389\u2013397 (2011).","journal-title":"Nat. Mater."},{"key":"66061_CR37","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/s41578-020-0230-0","volume":"5","author":"JG Croissant","year":"2020","unstructured":"Croissant, J. G. et al. Synthetic amorphous silica nanoparticles: toxicity, biomedical and environmental implications. Nat. Rev. Mater. 5, 886\u2013909 (2020).","journal-title":"Nat. Rev. Mater."},{"key":"66061_CR38","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/adfm.200600578","volume":"17","author":"K Moeller","year":"2007","unstructured":"Moeller, K., Kobler, J. & Bein, T. Colloidal suspensions of nanometer-sized mesoporous silica. Adv. Funct. Mater. 17, 605\u2013612 (2007).","journal-title":"Adv. Funct. Mater."},{"key":"66061_CR39","doi-asserted-by":"publisher","first-page":"6145","DOI":"10.1039\/c3nr00334e","volume":"5","author":"H Yamada","year":"2013","unstructured":"Yamada, H. et al. Preparation of aqueous colloidal mesostructured and mesoporous silica nanoparticles with controlled particle size in a very wide range from 20 nm to 700 nm. Nanoscale 5, 6145\u20136153 (2013).","journal-title":"Nanoscale"},{"key":"66061_CR40","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1021\/cm500619p","volume":"26","author":"E Yamamoto","year":"2014","unstructured":"Yamamoto, E. et al. Preparation of size-controlled monodisperse colloidal mesoporous silica nanoparticles and fabrication of colloidal crystals. Chem. Mater. 26, 2927\u20132933 (2014).","journal-title":"Chem. Mater."},{"key":"66061_CR41","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2217\/nnm.11.79","volume":"6","author":"JP Almeida","year":"2011","unstructured":"Almeida, J. P., Chen, A. L., Foster, A. & Drezek, R. In vivo biodistribution of nanoparticles. Nanomedicine 6, 815\u2013835 (2011).","journal-title":"Nanomedicine"},{"key":"66061_CR42","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jconrel.2012.05.046","volume":"163","author":"T Yu","year":"2012","unstructured":"Yu, T., Hubbard, D., Ray, A. & Ghandehari, H. In vivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics. J. Control. Release 163, 46\u201354 (2012).","journal-title":"J. Control. Release"},{"key":"66061_CR43","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1016\/j.biomaterials.2012.12.043","volume":"34","author":"C Fu","year":"2013","unstructured":"Fu, C. et al. The absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routes. Biomaterials 34, 2565\u20132575 (2013).","journal-title":"Biomaterials"},{"key":"66061_CR44","doi-asserted-by":"publisher","first-page":"114708","DOI":"10.1016\/j.addr.2023.114708","volume":"194","author":"M Kumar","year":"2023","unstructured":"Kumar, M., Kulkarni, P., Liu, S., Chemuturi, N. & Shah, D. K. Nanoparticle biodistribution coefficients: a quantitative approach for understanding the tissue distribution of nanoparticles. Adv. Drug Deliv. Rev. 194, 114708 (2023).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"66061_CR45","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12951-023-01994-0","volume":"21","author":"MR Hicks","year":"2023","unstructured":"Hicks, M. R. et al. Nanoparticles systemically biodistribute to regenerating skeletal muscle in DMD. J. Nanobiotechnol. 21, 303 (2023).","journal-title":"J. Nanobiotechnol."},{"key":"66061_CR46","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1096\/fj.13-237388","volume":"28","author":"KP Bibee","year":"2014","unstructured":"Bibee, K. P. et al. Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac function. FASEB J. 28, 2047\u20132061 (2014).","journal-title":"FASEB J."},{"key":"66061_CR47","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/gt.2013.57","volume":"21","author":"M Wang","year":"2014","unstructured":"Wang, M. et al. Pluronic-PEI copolymers enhance exon-skipping of 2\u2019-O-methyl phosphorothioate oligonucleotide in cell culture and dystrophic mdx mice. Gene Ther. 21, 52\u201359 (2014).","journal-title":"Gene Ther."},{"key":"66061_CR48","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1152\/physrev.00001.2003","volume":"83","author":"P Tuma","year":"2003","unstructured":"Tuma, P. & Hubbard, A. L. Transcytosis: crossing cellular barriers. Physiol. Rev. 83, 871\u2013932 (2003).","journal-title":"Physiol. Rev."},{"key":"66061_CR49","doi-asserted-by":"publisher","first-page":"e1339768","DOI":"10.1080\/21688370.2017.1339768","volume":"5","author":"CJ Ramos","year":"2017","unstructured":"Ramos, C. J. & Antonetti, D. A. The role of small GTPases and EPAC-Rap signaling in the regulation of the blood-brain and blood-retinal barriers. Tissue Barriers 5, e1339768 (2017).","journal-title":"Tissue Barriers"},{"key":"66061_CR50","doi-asserted-by":"crossref","unstructured":"Tavares, A. J. et al. Effect of removing Kupffer cells on nanoparticle tumor delivery. Proc. Natl. Acad. Sci. USA 114, E10871\u2013E10880 (2017).","DOI":"10.1073\/pnas.1713390114"},{"key":"66061_CR51","doi-asserted-by":"publisher","first-page":"6080","DOI":"10.1021\/acsnano.1c11578","volume":"16","author":"ZP Lin","year":"2022","unstructured":"Lin, Z. P. et al. Macrophages actively transport nanoparticles in tumors after extravasation. ACS Nano 16, 6080\u20136092 (2022).","journal-title":"ACS Nano"},{"key":"66061_CR52","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.coph.2017.04.002","volume":"34","author":"S Guiraud","year":"2017","unstructured":"Guiraud, S. & Davies, K. E. Pharmacological advances for treatment in Duchenne muscular dystrophy. Curr. Opin. Pharmacol. 34, 36\u201348 (2017).","journal-title":"Curr. Opin. Pharmacol."},{"key":"66061_CR53","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1002\/jps.20710","volume":"95","author":"CM Buchanan","year":"2006","unstructured":"Buchanan, C. M. et al. Solubilization and dissolution of tamoxifen-hydroxybutenyl cyclodextrin complexes. J. Pharm. Sci. 95, 2246\u20132255 (2006).","journal-title":"J. Pharm. Sci."},{"key":"66061_CR54","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.molmed.2006.01.002","volume":"12","author":"P Miura","year":"2006","unstructured":"Miura, P. & Jasmin, B. J. Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: How close are we? Trends Mol. Med. 12, 122\u2013129 (2006).","journal-title":"Trends Mol. Med."},{"key":"66061_CR55","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.nmd.2009.05.003","volume":"19","author":"K Nagaraju","year":"2009","unstructured":"Nagaraju, K. & Willmann, R. Developing standard procedures for murine and canine efficacy studies of DMD therapeutics: report of two expert workshops on \u201cPre-clinical testing for Duchenne dystrophy\u201d: Washington DC, October 27th-28th 2007 and Zurich, June 30th-July 1st 2008. Neuromuscul. Disord. 19, 502\u2013506 (2009).","journal-title":"Neuromuscul. Disord."},{"key":"66061_CR56","first-page":"L155","volume":"272","author":"P Baluk","year":"1997","unstructured":"Baluk, P. et al. Endothelial gaps: time course of formation and closure in inflamed venules of rats. Am. J. Physiol. 272, L155\u2013L170 (1997).","journal-title":"Am. J. Physiol."},{"key":"66061_CR57","first-page":"97","volume":"237","author":"HF Dvorak","year":"1999","unstructured":"Dvorak, H. F., Nagy, J. A., Feng, D., Brown, L. F. & Dvorak, A. M. Vascular permeability factor\/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr. Top. Microbiol. Immunol. 237, 97\u2013132 (1999).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"66061_CR58","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10456-008-9099-z","volume":"11","author":"JA Nagy","year":"2008","unstructured":"Nagy, J. A., Benjamin, L., Zeng, H., Dvorak, A. M. & Dvorak, H. F. Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis 11, 109\u2013119 (2008).","journal-title":"Angiogenesis"},{"key":"66061_CR59","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1016\/j.scib.2024.10.003","volume":"69","author":"M Qin","year":"2024","unstructured":"Qin, M., Feng, Z. & Meng, H. Enhanced transcytosis and retention (ETR) effect. Sci. Bull. 69, 3640\u20133643 (2024).","journal-title":"Sci. Bull."},{"key":"66061_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-61434-5","volume":"16","author":"Y Liu","year":"2025","unstructured":"Liu, Y. et al. Unlocking tumor barrier: annexin A2-mediated transcytosis boosts drug delivery in pancreatic and breast tumors. Nat. Commun. 16, 6531 (2025).","journal-title":"Nat. Commun."},{"key":"66061_CR61","doi-asserted-by":"publisher","first-page":"102435","DOI":"10.1016\/j.nantod.2024.102435","volume":"58","author":"E Casals","year":"2024","unstructured":"Casals, E., Vitali, M. & Puntes, V. The nanoparticle-protein corona untold history (1907\u20132007). Nano Today 58, 102435 (2024).","journal-title":"Nano Today"},{"key":"66061_CR62","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1369\/0022155412452417","volume":"60","author":"P Stuelsatz","year":"2012","unstructured":"Stuelsatz, P., Keire, P., Almuly, R. & Yablonka-Reuveni, Z. A contemporary atlas of the mouse diaphragm: myogenicity, vascularity, and the Pax3 connection. J. Histochem. Cytochem. 60, 638\u2013657 (2012).","journal-title":"J. Histochem. Cytochem."},{"key":"66061_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.mbplus.2023.100131","volume":"18","author":"RP Wohlgemuth","year":"2023","unstructured":"Wohlgemuth, R. P. et al. The extracellular matrix of dystrophic mouse diaphragm accounts for the majority of its passive stiffness and is resistant to collagenase digestion. Matrix Biol. Plus 18, 100131 (2023).","journal-title":"Matrix Biol. Plus"},{"key":"66061_CR64","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1152\/physrev.00045.2006","volume":"88","author":"DJ Duncker","year":"2008","unstructured":"Duncker, D. J. & Bache, R. J. Regulation of coronary blood flow during exercise. Physiol. Rev. 88, 1009\u20131086 (2008).","journal-title":"Physiol. Rev."},{"key":"66061_CR65","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41569-020-00499-9","volume":"18","author":"S Sahoo","year":"2021","unstructured":"Sahoo, S., Kariya, T. & Ishikawa, K. Targeted delivery of therapeutic agents to the heart. Nat. Rev. Cardiol. 18, 389\u2013399 (2021).","journal-title":"Nat. Rev. Cardiol."},{"key":"66061_CR66","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1152\/physrev.00032.2006","volume":"87","author":"P Ahuja","year":"2007","unstructured":"Ahuja, P., Sdek, P. & MacLellan, W. R. Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol. Rev. 87, 521\u2013544 (2007).","journal-title":"Physiol. Rev."},{"key":"66061_CR67","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1042\/BST20221296","volume":"52","author":"K Essandoh","year":"2024","unstructured":"Essandoh, K., Teuber, J. P. & Brody, M. J. Regulation of cardiomyocyte intracellular trafficking and signal transduction by protein palmitoylation. Biochem. Soc. Trans. 52, 41\u201353 (2024).","journal-title":"Biochem. Soc. Trans."},{"key":"66061_CR68","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/0022-2828(92)93381-S","volume":"24","author":"E Barth","year":"1992","unstructured":"Barth, E., St\u00e4mmler, G., Speiser, B. & Schaper, J. Ultrastructural quantitation of mitochondria and myofilaments in cardiac muscle from 10 different animal species including man. J. Mol. Cell. Cardiol. 24, 669\u2013681 (1992).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"66061_CR69","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1016\/j.peptides.2010.06.036","volume":"31","author":"Y Seow","year":"2010","unstructured":"Seow, Y., Yin, H. & Wood, M. J. Identification of a novel muscle targeting peptide in mdx mice. Peptides 31, 1873\u20131877 (2010).","journal-title":"Peptides"},{"key":"66061_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2012.30","volume":"1","author":"C Betts","year":"2012","unstructured":"Betts, C. et al. Pip6-PMO, a new generation of peptide-oligonucleotide conjugates with improved cardiac exon skipping activity for DMD treatment. Mol. Ther. Nucleic Acids 1, e38 (2012).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"66061_CR71","doi-asserted-by":"publisher","first-page":"102314","DOI":"10.1016\/j.nantod.2024.102314","volume":"56","author":"MM Mahmud","year":"2024","unstructured":"Mahmud, M. M., Pandey, N., Winkles, J. A., Woodworth, G. F. & Kim, A. J. Toward the scale-up production of polymeric nanotherapeutics for cancer clinical trials. Nano Today 56, 102314 (2024).","journal-title":"Nano Today"},{"key":"66061_CR72","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.stem.2016.01.021","volume":"18","author":"CS Young","year":"2016","unstructured":"Young, C. S. et al. A single CRISPR-Cas9 deletion strategy that targets the majority of DMD patients restores dystrophin function in hiPSC-derived muscle cells. Cell Stem Cell 18, 533\u2013540 (2016).","journal-title":"Cell Stem Cell"},{"key":"66061_CR73","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41556-017-0010-2","volume":"20","author":"MR Hicks","year":"2018","unstructured":"Hicks, M. R. et al. ERBB3 and NGFR mark a distinct skeletal muscle progenitor cell in human development and hPSCs. Nat. Cell Biol. 20, 46\u201357 (2018).","journal-title":"Nat. Cell Biol."},{"key":"66061_CR74","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1126\/science.2662404","volume":"244","author":"P Sicinski","year":"1989","unstructured":"Sicinski, P. et al. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244, 1578\u20131580 (1989).","journal-title":"Science"},{"key":"66061_CR75","doi-asserted-by":"publisher","first-page":"110939","DOI":"10.1016\/j.celrep.2022.110939","volume":"39","author":"J Zheng","year":"2022","unstructured":"Zheng, J. et al. Satellite cell-specific deletion of Cipc alleviates myopathy in mdx mice. Cell Rep. 39, 110939 (2022).","journal-title":"Cell Rep."},{"key":"66061_CR76","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s44318-024-00285-0","volume":"44","author":"RX Zhang","year":"2025","unstructured":"Zhang, R. X. et al. FNDC1 is a myokine that promotes myogenesis and muscle regeneration. EMBO J. 44, 30\u201353 (2025).","journal-title":"EMBO J."},{"key":"66061_CR77","doi-asserted-by":"publisher","first-page":"94","DOI":"10.5734\/JGM.2013.10.2.94","volume":"10","author":"YN Cho","year":"2013","unstructured":"Cho, Y. N. & Choi, Y. C. Female carriers of Duchenne muscular dystrophy. J. Genet. Med. 10, 94\u201398 (2013).","journal-title":"J. Genet. Med."},{"key":"66061_CR78","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","volume":"99","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y., Huo, M., Zhou, J. & Xie, S. PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput. Methods Programs Biomed. 99, 306\u2013314 (2010).","journal-title":"Comput. Methods Programs Biomed."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66061-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66061-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66061-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:02:15Z","timestamp":1766073735000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66061-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["66061"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-66061-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"21 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11217"}}